Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Generic drugs for hypertension: are they really equivalent?

Cooper-DeHoff RM, Elliott WJ.

Curr Hypertens Rep. 2013 Aug;15(4):340-5. doi: 10.1007/s11906-013-0353-4. Review.

2.

Similarity between generic and brand-name antihypertensive drugs for primary prevention of cardiovascular disease: evidence from a large population-based study.

Corrao G, Soranna D, Merlino L, Mancia G.

Eur J Clin Invest. 2014 Oct;44(10):933-9. doi: 10.1111/eci.12326.

PMID:
25132063
3.
4.

Medication persistence and the use of generic and brand-name blood pressure-lowering agents.

Corrao G, Soranna D, La Vecchia C, Catapano A, Agabiti-Rosei E, Gensini G, Merlino L, Mancia G.

J Hypertens. 2014 May;32(5):1146-53; discussion 1153. doi: 10.1097/HJH.0000000000000130. Erratum in: J Hypertens. 2015 Jul;33(7):1495. J Hypertens. 2015 Oct;33(10):2181.

PMID:
24569417
5.

Evaluating the bioavailability and bioequivalence of generic medications.

Howland RH.

J Psychosoc Nurs Ment Health Serv. 2010 Jan;48(1):13-6. doi: 10.3928/02793695-20091204-07.

PMID:
20102127
6.

Potential concerns about generic substitution: bioequivalence versus therapeutic equivalence of different amlodipine salt forms.

Meredith PA.

Curr Med Res Opin. 2009 Sep;25(9):2179-89. doi: 10.1185/03007990903116867. Review.

PMID:
19601710
7.

Generic substitution of antihypertensive drugs: does it affect adherence?

Van Wijk BL, Klungel OH, Heerdink ER, de Boer A.

Ann Pharmacother. 2006 Jan;40(1):15-20. Epub 2005 Nov 22.

PMID:
16303985
8.

[Influence of substitution of brand name for generic drugs on therapeutic compliance in hypertension and dyslipidemia].

Mainar AS, Artieda RN.

Gac Sanit. 2010 Nov-Dec;24(6):473-82. doi: 10.1016/j.gaceta.2010.07.007. Epub 2010 Oct 20. Spanish.

9.

Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: an 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial.

Kim SH, Chung WY, Zo JH, Kim MA, Chang HJ, Cho YS, Youn TJ, Chae IH, Choi DJ, Gwak JJ, Lee HY, Park JS, Kang HJ, Kim YJ, Kim HS.

Clin Ther. 2009 May;31(5):988-98. doi: 10.1016/j.clinthera.2009.05.020.

PMID:
19539099
10.

What makes a generic medication generic?

Howland RH.

J Psychosoc Nurs Ment Health Serv. 2009 Dec;47(12):17-20. doi: 10.3928/02793695-20091103-99.

PMID:
20000278
11.

Improving outcomes in hypertensive patients: focus on adherence and persistence with antihypertensive therapy.

Elliott WJ.

J Clin Hypertens (Greenwich). 2009 Jul;11(7):376-82. doi: 10.1111/j.1751-7176.2009.00138.x. Review.

12.

[Evaluation of efficacy and safety of hypertension treatment with original angiotensin-converting enzyme inhibitors: the comparison of original and generic formulations].

Szczotka B, Jaźwińska-Tarnawska E, Wedlarski R, Łapiński Ł, Wiela-Hojeńska A.

Pol Merkur Lekarski. 2013 Mar;34(201):140-4. Polish.

PMID:
23700822
13.

Comparison in vitro felodipine release rate from the original versus generic product with controlled release of the drug.

Vetchy D, Vetcha M, Rabiskova M, Gryczova E, Bartosikova L.

Medicina (Kaunas). 2007;43(4):326-31.

14.

When is a "generic" medication not really a generic?

Howland RH.

J Psychosoc Nurs Ment Health Serv. 2010 Feb;48(2):13-6. doi: 10.3928/02793695-20100108-98.

PMID:
20166651
15.

Use and cost of branded and generic drugs in patients with coronary heart disease--results from a prospective survey of 1008 patients in two London hospitals.

Corp EV, Antoniou S, Wright PG, Khachi H, Vercaeren S, Wald DS.

QJM. 2009 Dec;102(12):843-9. doi: 10.1093/qjmed/hcp127. Epub 2009 Oct 14.

PMID:
19828644
16.

[Generic drugs: brand names and the placebo effect].

Caamaño-Isorna F.

Gac Sanit. 2013 Sep-Oct;27(5):468-9. doi: 10.1016/j.gaceta.2012.11.013. Epub 2013 Feb 18. Spanish. No abstract available.

17.

Rational use of generic psychotropic drugs.

Carbon M, Correll CU.

CNS Drugs. 2013 May;27(5):353-65. doi: 10.1007/s40263-013-0045-2. Review.

PMID:
23620145
18.

Generic immunosuppression in solid organ transplantation: a Canadian perspective.

Harrison JJ, Schiff JR, Coursol CJ, Daley CJ, Dipchand AI, Heywood NM, Keough-Ryan TM, Keown PA, Levy GA, Lien DC, Wichart JR, Cantarovich M.

Transplantation. 2012 Apr 15;93(7):657-65. doi: 10.1097/TP.0b013e3182445e9d. Review.

PMID:
22267158
19.

Generic and branded drugs for the treatment of people living with HIV/AIDS.

Bartlett JA, Muro EP.

J Int Assoc Physicians AIDS Care (Chic). 2007 Mar;6(1):15-23. Review.

PMID:
17329500
20.

A review of the safety of generic drugs.

Dighe SV.

Transplant Proc. 1999 May;31(3A Suppl):23S-24S. Review.

PMID:
10330955

Supplemental Content

Support Center